+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Theravance Biopharma - logo

Theravance Biopharma is a biopharmaceutical company that develops and commercializes human therapeutics. The company offers VIBATIV (telavancin), a bactericidal, once-daily injectable antibiotic. In addition, it has numerous product candidates, including Revefenacin (TD-4208), Axelopran, Velusetrag, TD-6450 and others. It also focuses on various drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. Founded in 2013, it is based in George Town, the Cayman Islands.

Ulcerative Colitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ulcerative Colitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 714 Pages
  • Global
From
Diabetic Gastroparesis Treatment Market Report 2025 - Product Thumbnail Image

Diabetic Gastroparesis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Celiac Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Celiac Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 122 Pages
  • Global
From
Peptide Antibiotics Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Peptide Antibiotics Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • November 2023
  • 115 Pages
  • Global
From
Crohn's Disease (Regional Enteritis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 632 Pages
  • Global
From
Bacterial Pneumonia - Pipeline Insight, 2025 - Product Thumbnail Image

Bacterial Pneumonia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ulcerative Colitis - Pipeline Insight, 2025 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Diabetic Gastroparesis (DGp) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Diabetic Gastroparesis (DGp) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors Market Report 2025 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Diabetic Gastroparesis Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Diabetic Gastroparesis Treatment Market Report and Forecast 2024-2032

  • Report
  • October 2024
  • 200 Pages
  • Global
From
Anti Asthmatic Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Anti Asthmatic Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • March 2022
  • 101 Pages
  • Global
From
Methicillin Resistant Staphylococcus Aureus Drugs Market - Growth, Trends, and Forecasts (2020 - 2025) - Product Thumbnail Image

Methicillin Resistant Staphylococcus Aureus Drugs Market - Growth, Trends, and Forecasts (2020 - 2025)

  • Report
  • June 2020
  • 114 Pages
  • Global
From
Diabetic Gastroparesis - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Gastroparesis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2025 - Product Thumbnail Image

Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2025

  • Report
  • April 2025
  • 450 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 541 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 500 Pages +
  • Global
From
Pneumatic Nebulizers Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Pneumatic Nebulizers Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025 - Product Thumbnail Image

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025

  • Report
  • April 2025
  • 750 Pages
  • Global
From
Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 589 Pages
  • Global
From
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025 - Product Thumbnail Image

Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Loading Indicator